The University of Hong Kong: Hepatitis B, Chronic trials
The registry lists 10 Hepatitis B, Chronic studies with The University of Hong Kong as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 2 1Phase 3 1Phase 4 2No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Linkage to Care and Treatment of Chronic HBV PatientsCompletedNCT06658678Not applicable
- Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B PatientsActive, not recruitingNCT05147090Phase 4
- Stopping Antiviral Treatment in Chronic Hepatitis BActive, not recruitingNCT04431245
- Renoprotective Effects of Telbivudine in Chronic Hepatitis BCompletedNCT03778567Phase 4
- Quality of Life and Health Utility of Patients With CHB InfectionsCompletedNCT03329820
- Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus CarriersStatus unknownNCT02991638Phase 3
- Off Treatment Durability in Chronic Hepatitis B With Good Immune ControlCompletedNCT02738554Not applicable
- Tenofovir in Asian Chronic Hepatitis B PatientsCompletedNCT01728935Not applicable
- Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral LoadCompletedNCT01013272Not applicable
- Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)CompletedNCT00804622Phase 2